Search results
Tiger Aesthetics Medical, LLC Acquires Assets of Sientra, Inc.
Digital Journal· 5 days agoVienna ball season back in full swing ‘Avatar 2’ success proves cinema in post-pandemic ‘resurgence’: Cameron North of ...
Essense of Australia Celebrates 'That First Look' in New Collection
Digital Journal· 5 days agoAnnounces Fiscal Second Quarter and Fiscal First Half 2024 Financial Results Dolphin ...
Targeting specific protein regions offers a new treatment approach in medulloblastoma
Medical Xpress· 4 days agoThe findings are reported in Nature Communications. Previous research by St. Jude scientists and others has classified medulloblastoma into four distinct molecular groups: WNT and SHH—driven ...
Critical Survey: Coeptis Therapeutics (COEP) versus The Competition
ETF DAILY NEWS· 4 days agoCoeptis Therapeutics (NASDAQ:COEP – Get Free Report) is one of 289 publicly-traded companies in the “Biological products, except diagnostic” industry, but how does it compare to its peers? We ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 days agoSAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that it will
Biophytis Announces Transfer of ADSs to OTC Market
Digital Journal· 5 days agoAnnounces Fiscal Second Quarter and Fiscal First Half 2024 Financial Results More from Digital...
ImmunityBio Inc. Drug Approved By FDA
The Post-Journal· 4 days agoPictured is the ImmunityBio production facility on Route 5 in Dunkirk. A monumental achievement for ImmunityBio, Inc. occurred earlier this week, leaving...
Eagles sweep Panthers in county rematch
The Herald Bulletin· 4 days agoAt least it was dry the second time around. Less than two weeks after barely finishing their Madison County first-round match on a chilly and damp...
Ayala Pharmaceuticals (NASDAQ:ADXS) Earns Sell Rating from Analysts at StockNews.com
ETF DAILY NEWS· 4 days agoStockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Free Report) in a research note released on Wednesday. The firm issued a sell rating on the stock. Ayala Pharmaceuticals ...
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against bluebird bio,...
Morningstar· 5 days agoPomerantz LLP announces that a class action lawsuit has been filed against bluebird bio, Inc. (“bluebird” or the “Company”) (NASDAQ: BLUE). Such investors are advised to contact Danielle Peyton ...
